Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coated tablets and profiling degradants

• 主要な著者: María del Mar Contreras (著者), Aránzazu Morales-Soto (著者), Antonio Segura-Carretero (著者), Javier Valverde (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2017-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Sofosbuvir is one of the new direct-acting antiviral drugs against hepatitis C virus (HCV) infection. This drug has recently been launched into the market, and generic versions of the medication are expected to be produced by local drug producers in some countries. Therefore, new methods are require...